Wednesday, September 30, 2020

MetLife Inc. [MET] is -25.00% lower this YTD. Is it still time to buy?

Must read

MICT Inc. [MICT] Stock trading around $3.08 per share: What’s Next?

MICT Inc. stock went on a downward path that fall over -20.00% on Thursday, amounting to a one-week price decrease of less than...

AgEagle Aerial Systems Inc. [UAVS] Is Currently -4.15 below its 200 Period Moving Avg: What Dose This Mean?

AgEagle Aerial Systems Inc. loss -4.15% or -0.11 points to close at $2.54 with a heavy trading volume of 3484787 shares. The company...

Market Analysts see Cerus Corporation [CERS] gaining to $9. Time to buy?

Cerus Corporation traded at a high on 09/25/20, posting a 3.05 gain after which it closed the day’ session at $6.08. The results...

Market Analysts see Prospect Capital Corporation [PSEC] gaining to $4.50. Time to buy?

Prospect Capital Corporation closed the trading session at $4.98 on 09/23/20. The day’s price range saw the stock hit a low of $4.96,...

MetLife Inc. [NYSE: MET] gained 1.43% on the last trading session, reaching $38.23 price per share at the time. The company report on August 26, 2020 that MetLife Investment Management Originates $6.2 Billion in Private Placement Debt For 1H 2020.

Private placement debt portfolio grows to $91.2 billion1.

MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced it originated $6.2 billion in private placement debt for the first half of 2020, across nearly 100 transactions. This included $1.7 billion of investments originated on behalf of institutional clients.

MetLife Inc. represents 908.80 million in outstanding shares, while the company has a total market value of $34.21 billion with the latest information. MET stock price has been found in the range of $37.57 to $38.48.

If compared to the average trading volume of 5.59M shares, MET reached a trading volume of 5306582 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about MetLife Inc. [MET]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MET shares is $45.27 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MET stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA/Merrill have made an estimate for MetLife Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 01, 2020. While these analysts kept the previous recommendation, Citigroup dropped their target price from $46 to $32. The new note on the price target was released on March 16, 2020, representing the official price target for MetLife Inc. stock. Previously, the target price had yet another raise from $55 to $60, while Morgan Stanley kept a Overweight rating on MET stock.

The Average True Range (ATR) for MetLife Inc. is set at 1.15, with the Price to Sales ratio for MET stock in the period of the last 12 months amounting to 0.50. The Price to Book ratio for the last quarter was 0.46, with the Price to Cash per share for the same quarter was set at 27.14. Price to Free Cash Flow for MET in the course of the last twelve months was 3.30.

Trading performance analysis for MET stock

MetLife Inc. [MET] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.08. With this latest performance, MET shares dropped by -4.52% in over the last four-week period, additionally plugging by 19.73% over the last 6 months – not to mention a drop of -20.14% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MET stock in for the last two-week period is set at 48.28, with the RSI for the last a single of trading hit 48.32, and the three-weeks RSI is set at 50.04 for MetLife Inc. [MET]. The present Moving Average for the last 50 days of trading for this stock 38.14, while it was recorded at 38.25 for the last single week of trading, and 40.44 for the last 200 days.

MetLife Inc. [MET]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and MetLife Inc. [MET] shares currently have an operating margin of +10.49. MetLife Inc.’s Net Margin is presently recorded at +8.58.

Return on Total Capital for MET is now 9.24, given the latest momentum, and Return on Invested Capital for the company is 7.62. Return on Equity for this stock inclined to 9.92, with Return on Assets sitting at 0.82. When it comes to the capital structure of this company, MetLife Inc. [MET] has a Total Debt to Total Equity ratio set at 29.48. Additionally, MET Total Debt to Total Capital is recorded at 22.77, with Total Debt to Total Assets ending up at 2.61. Long-Term Debt to Equity for the company is recorded at 28.69, with the Long-Term Debt to Total Capital now at 22.16.

Reflecting on the efficiency of the workforce at the company, MetLife Inc. [MET] managed to generate an average of $120,388 per employee.

MetLife Inc. [MET]: An earnings per share (EPS) analysis

With the latest financial reports released by the company, MetLife Inc. posted 1.27/share EPS, while the average EPS was predicted by analysts to be reported at 1.39/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -8.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MET. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MetLife Inc. go to 2.39%.

An analysis of insider ownership at MetLife Inc. [MET]

There are presently around $26,588 million, or 78.30% of MET stock, in the hands of institutional investors. The top three institutional holders of MET stocks are: BLACKROCK INC. with ownership of 69,956,785, which is approximately 6.569% of the company’s market cap and around 0.10% of the total institutional ownership; DODGE & COX, holding 66,337,971 shares of the stock with an approximate value of $2.54 billion in MET stocks shares; and VANGUARD GROUP INC, currently with $2.38 billion in MET stock with ownership of nearly -2.351% of the company’s market capitalization.

Positions in MetLife Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 429 institutional holders increased their position in MetLife Inc. [NYSE:MET] by around 52,907,798 shares. Additionally, 498 investors decreased positions by around 49,951,163 shares, while 150 investors held positions by with 592,626,614 shares. The mentioned changes placed institutional holdings at 695,485,575 shares, according to the latest SEC report filing. MET stock had 107 new institutional investments in for a total of 6,419,228 shares, while 84 institutional investors sold positions of 3,172,404 shares during the same period.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Bill.com Holdings Inc. [BILL] stock Reiterated by Needham analyst, price target now $120

Bill.com Holdings Inc. stock went on an upward path that rose over 4.20% on Tuesday, amounting to a one-week price increase of more...

Salem Media Group Inc. [SALM] is -31.22% lower this YTD. Is it still time to buy?

Salem Media Group Inc. gained 4.26% on the last trading session, reaching $0.99 price per share at the time. Salem Media Group Inc....

For At Home Group Inc. [HOME], Monness Crespi & Hardt sees a rise to $20. What next?

At Home Group Inc. surged by $0.61 during the normal trading session on Tuesday and reaching a high of $15.62 during the day...

Market Analysts see Hancock Jaffe Laboratories Inc. [HJLI] gaining to $3. Time to buy?

Hancock Jaffe Laboratories Inc. traded at a high on 09/29/20, posting a 4.35 gain after which it closed the day’ session at $0.44....

Darling Ingredients Inc. [DAR] Revenue clocked in at $3.40 billion, up 26.18% YTD: What’s Next?

Darling Ingredients Inc. price surged by 4.61 percent to reach at $1.56. A sum of 2154706 shares traded at recent session while its...